Abstract
Our previous studies showed that anti-CD3 activated T cells (ATC) from peripheral blood mononuclear cells could be expanded in interleukin-2 (IL-2) for 14 days and armed with anti-CD3 x anti-Her2/neu (Her2Bi)[
J Hemat & Stem Cell Res
10
:247
,2001
Exp Hemat
33
:452
,2005
Clin Cancer Res
12
:183
,2006
Author notes
Disclosure: Ownership Interests: Lawrence Lum is founder of Transtarget. Membership Information: Lawrence Lum on speaker’s bureau for Berlex. Off Label Use: Use of IL-2 and GM-CSF.
2007, The American Society of Hematology
2007
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal